The FEBS-IUBMB-ENABLE Conference is a joint initiative of FEBS, IUBMB, and several leading European biomedical research institutes (the ENABLE partners), building on a successful project originally funded by the EU Horizon 2020 Research and Innovation Programme (2017–2020). These interdisciplinary, international, three-day events are organized by and for young researchers in the molecular life sciences and attract up to 300 participants from around the world. Each conference features a scientific symposium, a career day, and outreach activities. ENABLE (the European Academy for Biomedical Science) was launched in 2017 through the collaboration of four renowned European institutes: the Institute for Research in Biomedicine (IRB Barcelona, Spain), the Novo Nordisk Foundation Center for Protein Research (NNF-CPR, Denmark), the Radboud Institute for Molecular Life Sciences at Radboudumc (Netherlands), and the European School of Molecular Medicine (SEMM, Italy). These core institutions hosted the first four conferences from 2017 to 2021. In 2022, FEBS and IUBMB joined forces with the ENABLE founders to relaunch the initiative as FEBS-IUBMB-ENABLE, expanding its reach and impact. In this new cycle, institutions can apply to become associated centres and host one of the events. 

https://scholar.google.com/citations?user=p8dQbaUAAAAJ https://www.webofscience.com/wos/author/record/H-4020-2013 https://www.scopus.com/authid/detail.uri?authorId=55711821300 https://www.researchgate.net/profile/Maxim-Ponomarev https://orcid.org/0000-0002-7530-3116 https://en.wikipedia.org/wiki/List_of_plasma_physicists

'FEBS Communications' posts general items from the FEBS Network Team as well as news on FEBS events and other activities.

FEBS Letters is renowned both for its quality of content and speed of production. Bringing together the most important developments in the molecular biosciences, FEBS Letters provides an international forum for Reviews, Research Letters and Research Articles that merit urgent publication.